UNSPSC 51162402: Acetaminophen/dextromethorphan/guaifenesin/phenylephrine
Commodity
Code facts
- Part of
-
-
51000000
-
51160000
- 51162400
-
51160000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51162402
Definition
This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE514. This VA Drug Class (RE514) classifies this compound as belonging to the group DECONGESTANT/ANTITUSSIVE/EXPECTORANT/ANALGESIC.
The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.
Read the full definition
The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification.
The second component of this combination drug is an opioid receptor agonist and opioid with the molecular formula C18H25NO, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 7355X3ROTS, chemically known as 2h-10,4a-iminoethanophenanthrene, 1,3,4,9,10,10a-hexahydro-6-methoxy-11-methyl- but more generally known as dextromethorphan, which bears U.S. National Institutes of Health Compound Identifier 3008.
The European Medicines Agency schedules Dextromethorphan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07051MIG. The term DEXTROMETHORPHAN is an International Non-Proprietary Name. The World Health Organization schedules dextromethorphan in its Anatomical Therapeutic Chemical (ATC) Classification.
The third component of this combination drug is an expectorant with the molecular formula C10H14O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 495W7451VQ, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears U.S. National Institutes of Health Compound Identifier 3516. The European Medicines Agency schedules Guaifenesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07973MIG.
The term GUAIFENESIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25, No. 10 1971, List 11). The World Health Organization schedules guaifenesin in its Anatomical Therapeutic Chemical (ATC) Classification.
The fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula C9H13NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 1WS297W6MV, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears U.S. National Institutes of Health Compound Identifier 6041. The European Medicines Agency schedules Phenylephrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09788MIG.
The term PHENYLEPHRINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 30, No. 10 1976, List 16). The World Health Organization schedules phenylephrine in its Anatomical Therapeutic Chemical (ATC) Classification.
About UNSPSC 51162402
UNSPSC 51162402 Acetaminophen/dextromethorphan/guaifenesin/phenylephrine is a Commodity code, but the recent state and local solicitations tagged under it do not align with the code's nominal scope. The posted opportunities target naloxone and drug deactivation systems (Seminole County, Florida) and generic multi-source pharmaceuticals and OTC products broadly (Minnesota Multistate Cooperative Purchasing Alliance), neither of which matches the specific cold and cough combination product described by the code number. State and local procurement systems occasionally misalign product taxonomies with actual solicitation scope, and this code shows minimal recent activity in the product category it nominates.
The two opportunities on record span different issuing-body types and geographic footprints. Seminole County, a county-level health procurement entity in Florida, issued an IFB in June 2026 for naloxone and drug deactivation systems with a July 26, 2023 response deadline (posting dates and due dates in the source carry inconsistent timestamps). MMCAP, a multistate cooperative purchasing vehicle administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 for generic and OTC pharmaceutical products to serve participating state and local government facilities across Minnesota and Oregon, with proposals due March 26, 2026. The mismatch between the code's name and the actual procurement scope suggests this code may not be the appropriate category for tracking relevant opportunities in acetaminophen-containing combination products.
Quick answers
What is UNSPSC 51162402?
UNSPSC 51162402 is Acetaminophen/
Which NIGP codes match UNSPSC 51162402?
UNSPSC 51162402 maps to 1 NIGP code, 26948 Expectorants, Antitussives, and Mucolytic Agents.
On GovTribe
See everything under UNSPSC 51162402
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code